UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics
URGN Price/Volume Stats
| Current price | $15.27 | 52-week high | $17.00 |
| Prev. close | $15.41 | 52-week low | $3.42 |
| Day low | $14.89 | Volume | 1,061,273 |
| Day high | $15.80 | Avg. volume | 1,606,083 |
| 50-day MA | $10.35 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 705.49M |
URGN Stock Price Chart Interactive Chart >
UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio
UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.
URGN Price Returns
| 1-mo | 2.69% |
| 3-mo | N/A |
| 6-mo | 48.69% |
| 1-year | -8.23% |
| 3-year | 68.17% |
| 5-year | -39.50% |
| YTD | 43.38% |
| 2024 | -29.00% |
| 2023 | 69.11% |
| 2022 | -6.73% |
| 2021 | -47.23% |
| 2020 | -46.00% |
Loading social stream, please wait...